Results of a study comparing controlled immunotherapy versus vaccine MyVax for follicular lymphoma. Results showed no additional clinical benefit for controlled immunotherapy and the participants given MyVax had superior PFS.
Home / Resource Library / Active Idiotypic Vaccination Versus Control Immunotherapy for Follicular Lymphoma